Skip to main content
. 2014 May 22;2014:407026. doi: 10.1155/2014/407026

Figure 3.

Figure 3

Overall survival (a) and progression-free survival (b) for all patients. Median OS was 20.0 months, and the 1- and 2-year OS rates were 71.2% and 26.3%, respectively. Median PFS was 13.0 months, and the 1- and 2-year PFS rates were 52.6% and 20.6%, respectively.